169 related articles for article (PubMed ID: 23073296)
1. VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population.
Sáenz-López P; Vazquez F; Cozar JM; Carretero R; Garrido F; Ruiz-Cabello F
Hum Immunol; 2013 Jan; 74(1):98-103. PubMed ID: 23073296
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies.
Gong M; Dong W; Shi Z; Qiu S; Yuan R
Oncotarget; 2017 Jan; 8(5):8447-8458. PubMed ID: 28039484
[TBL] [Abstract][Full Text] [Related]
3. Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma.
Yang SM; Huang CY; Shiue HS; Huang SP; Pu YS; Chen WJ; Lin YC; Hsueh YM
PLoS One; 2015; 10(12):e0145410. PubMed ID: 26701102
[TBL] [Abstract][Full Text] [Related]
4. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control study.
Lu G; Dong Y; Zhang Q; Jiao L; Yang S; Shen B
Tumour Biol; 2015 Nov; 36(11):8645-52. PubMed ID: 26044558
[TBL] [Abstract][Full Text] [Related]
6. VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib.
Scartozzi M; Bianconi M; Faloppi L; Loretelli C; Bittoni A; Del Prete M; Giampieri R; Maccaroni E; Nicoletti S; Burattini L; Minardi D; Muzzonigro G; Montironi R; Cascinu S
Br J Cancer; 2013 Mar; 108(5):1126-32. PubMed ID: 23511629
[TBL] [Abstract][Full Text] [Related]
7. Relationship between VEGFA polymorphisms and serum VEGF protein levels and recurrent spontaneous miscarriage.
Almawi WY; Saldanha FL; Mahmood NA; Al-Zaman I; Sater MS; Mustafa FE
Hum Reprod; 2013 Oct; 28(10):2628-35. PubMed ID: 23900206
[TBL] [Abstract][Full Text] [Related]
8. Impact of Vascular Endothelial Growth Factor Gene Polymorphisms and Their Interactions with Environmental Factors on Susceptibility to Renal Cell Carcinoma.
Liu F; Wen T; Tang Q; Chen F; Liao D
Nephron; 2020; 144(5):255-260. PubMed ID: 32182617
[TBL] [Abstract][Full Text] [Related]
9. Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.
Zhong W; Wang X; Pan B; Su Z
Tumour Biol; 2014 Oct; 35(10):9839-45. PubMed ID: 24989926
[TBL] [Abstract][Full Text] [Related]
10. Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients.
Supic G; Jovic N; Zeljic K; Kozomara R; Magic Z
Oral Oncol; 2012 Nov; 48(11):1171-7. PubMed ID: 22818823
[TBL] [Abstract][Full Text] [Related]
11. Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis.
Hou Q; Li MY; Huang WT; Wei FF; Peng JP; Lou MW; Qiu JG
Oncotarget; 2017 Jul; 8(30):50061-50070. PubMed ID: 28562357
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas.
Xian W; Zheng H; Wu WJ
Genet Mol Res; 2015 Jul; 14(3):7634-42. PubMed ID: 26214443
[TBL] [Abstract][Full Text] [Related]
13. Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study.
Shen BL; Qu QS; Miao SZ; Zhang YX
Genet Mol Res; 2015 Sep; 14(3):11119-25. PubMed ID: 26400342
[TBL] [Abstract][Full Text] [Related]
14. Predictive role of vascular endothelial growth factor polymorphisms in the survival of renal cell carcinoma patients.
Yang YQ; Chen J
Genet Mol Res; 2014 Jul; 13(3):5011-7. PubMed ID: 25062489
[TBL] [Abstract][Full Text] [Related]
15. Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis.
Tang J; Qin Z; Li X; Han P; Wang F; Yang C; Li R; Wang K; Tang M; Wang W; Lv Q; Zhang W
Oncotarget; 2017 Jul; 8(30):50034-50050. PubMed ID: 28489583
[TBL] [Abstract][Full Text] [Related]
16. Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population.
Li Z; Wang Y; Liu C; Wang Z; Wang D; Liang X; Tian J
Breast Cancer Res Treat; 2021 Feb; 186(1):149-156. PubMed ID: 33392836
[TBL] [Abstract][Full Text] [Related]
17. VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population.
Maltese P; Canestrari E; Ruzzo A; Graziano F; Falcone A; Loupakis F; Tonini G; Santini D; Magnani M
Int J Colorectal Dis; 2009 Feb; 24(2):165-70. PubMed ID: 18830612
[TBL] [Abstract][Full Text] [Related]
18. Investigating the association of vascular endothelial growth factor polymorphisms with breast cancer: a Moroccan case-control study.
Rahoui J; Laraqui A; Sbitti Y; Touil N; Ibrahimi A; Ghrab B; Al Bouzidi A; Moussaoui Rahali D; Dehayni M; Ichou M; Zaoui F; Mrani S
Med Oncol; 2014 Sep; 31(9):193. PubMed ID: 25148899
[TBL] [Abstract][Full Text] [Related]
19. Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects.
Song Y; Hu J; Chen Q; Guo J; Zou Y; Zhang W; Chen X; Hu W; Huang P
Gene; 2018 Dec; 679():241-252. PubMed ID: 30195633
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinoma.
Bianconi M; Faloppi L; Loretelli C; Zizzi A; Giampieri R; Bittoni A; Andrikou K; Del Prete M; Burattini L; Montironi R; Scartozzi M; Cascinu S
Oncotarget; 2016 Jun; 7(25):37599-37607. PubMed ID: 27175586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
